Literature DB >> 22137784

Prediction of infarct growth and neurologic deterioration in patients with positive perfusion-diffusion mismatch.

Chien-Tai Hong1, Yu Sun, Chien-Jung Lu, Hsiu-Chen Shin, Rong-Chi Chen.   

Abstract

BACKGROUND: To assess the value of baseline clinical severity and perfusion-diffusion mismatch as predictors for further infarct growth and clinical outcome.
METHODS: Patients with acute ischemic stroke and initial perfusion-diffusion mismatch within 72 h were enrolled. Baseline perfusion defects on time-to-peak (TTP) and cerebral blood volume (CBV) maps were measured. Infarct volume and stroke severity were assessed by diffusion-weighted image (DWI) and NIHSS, and were repeatedly assessed 7 days later. The predictive value of baseline NIHSS and perfusion defects on further infarct growth and neurologic deterioration was determined.
RESULTS: Fifty-two patients (mean age 68.3±12.8 years, 42% women) were enrolled. CBV defects were significantly associated with infarct growth (CBV, p=0.02). Initial stroke severity, but not TTP and CBV mismatch (p=0.65 and 0.76, respectively), significantly inversely correlated with neurologic deterioration (p=0.001).
CONCLUSIONS: In patients with mismatch, those with severe symptoms initially are more likely to have infarct growth, while those with minor symptoms tend to suffer from larger extent of neurologic deterioration within 1 week. CBV is associated with further infarct growth but not clinical deterioration.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22137784     DOI: 10.1016/j.clineuro.2011.11.019

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  1 in total

1.  Successful outcome after endovascular thrombolysis for acute ischemic stroke with basis on perfusion-diffusion mismatch after 24 h of symptoms onset.

Authors:  Tobias A Mattei; Azeem A Rehman; Carlos R Goulart; Marília G Sória; Vanessa Rizelio; Murilo S Meneses
Journal:  Surg Neurol Int       Date:  2016-06-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.